Natural pattern-recognition-receptor agonists in prophylactic vaccines for in situ vaccination of lymphoma.

e14516Background: In patients with advanced-stage lymphoma, in situ vaccination has yielded partial and complete remissions in phase I/II clinical trials. Though responses have been observed with v...